HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Hillhouse Capital Related

477.614

-14.602-2.97%

Number of Gainers:9

Number of Losers:40

Number of Flat:2

PE:- -

High:492.483

Open:492.216

Low:476.477

Close:492.216

Volume:448.98M

Turnover:13.45B

Market Cap:3.01T

Float Cap:2.11T

Loading ...

Genscript Biotech Says H1 Adjusted Net Profit up 203.3% Y/Y, Revenue up 27.3%

THOMSON REUTERS

GENSCRIPT BIO Reports Interim Results: Net Loss Narrows 29.25% to $129 Million

GenScript FY26 H1 Net Loss Narrows 28.9% to US$ 129.34 Million; Revenue Rises 27.3% to US$ 404.22 Million

JD Health International, Inc. (6618) Gets a Buy from CSC Financial

Why Xtep International Holdings (SEHK:1368) Is Back In The Spotlight

Simply Wall St.

JD Health (SEHK:6618) Stock Marks Nine Straight Quarters Of Margin Gains

Simply Wall St.

JD Health International, Inc. (6618) Receives a Buy from CLSA

Shandong Boan Biotech Completes China Phase Ia Trial of Ba1302 CD228-Targeted ADC

Shandong Boan Biotech Schedules Board Meeting on Interim Results, Dividend Review

How CR Mixc Elevates Community Malls: A Deep Dive into Shenzhen Buji Mixc's Premium Strategy

JPMorgan Chase & Co. Increases Stake in BEONE MEDICINES by Over 4.1 Million Shares at Approximately HKD 219.79 Each

Liu Xiaopeng receives approval for vice president role at Cinda Asset

Record highs: Beijing-Tianjin-Hebei region sees 15.6% growth in imports and exports for first seven months

MicroPort CardioFlow Schedules Board Meeting to Review Interim Results, Consider Dividend

Xiabuxiabu Schedules Board Meeting to Review Interim Results, Consider Dividend

JPMorgan Chase's Short Position in H-Shares of WuXi AppTec Increases to 3.19% on Aug 11 from 2.66% - HKEX

THOMSON REUTERS

Everest Medicines Files Board, Board Committee Member List with Disclosure Responsibilities

Tong Ren Tang Technologies Schedules Board Meeting on Interim Results, Dividend Decision

China Resources Mixc Lifestyle Services Schedules Board Meeting to Review Interim Results, Dividend Plan

Haidilao International Holding Stock Falls 1.5% in Hong Kong

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/BK1583/news?page=12"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK1583","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1583\",,,,,undefined,":{"symbol":"BK1583","market":"HK","secType":"PLATE","nameCN":"Hillhouse Capital Related","latestPrice":477.61407,"timestamp":1787558899038,"preClose":492.21594,"halted":0,"volume":448977889,"delay":0,"changeRate":-0.029666,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":-14.601868,"latestTime":"08-24 16:00:00","open":492.21594,"high":492.48306,"low":476.4772,"amount":13451380024.5,"amplitude":0.032518,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787621400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1787535000000,1787544000000],[1787547600000,1787558400000]],"pbRate":2.251969,"peRate":52.53658,"turnoverRate":0.004085,"increases":6,"decrements":42,"flats":3,"marketCap":3006262293376,"floatMarketCap":2108846506848},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1583\",,,,,undefined,":{"symbol":"BK1583","high":492.48306,"amplitude":0.032518,"preClose":492.21594,"low":476.4772,"pbRate":"2.251969","latestPrice":477.61407,"volume":448977889,"delay":0,"open":492.21594,"prevYearClose":503.90085,"prevWeekClose":492.216,"prevMonthClose":470.497,"prevQuarterClose":402.118,"fiveDayClose":483.304,"twentyDayClose":465.583,"sixtyDayClose":424.514,"secType":"PLATE","market":"HK","turnoverRate":0.004085,"peRate":52.53658,"marketCap":3006262293376,"floatMarketCap":2108846506848,"timestamp":1787558899038,"nameCN":"Hillhouse Capital Related"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1583\",,,,undefined,":{"bkCode":"BK1583","up":9,"down":40,"flat":2},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1583\",pageSize:20,pageCount:12,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2659172878","title":"Genscript Biotech Says H1 Adjusted Net Profit up 203.3% Y/Y, Revenue up 27.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2659172878","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659172878?lang=en_us&edition=fundamental","pubTime":"2026-08-16 18:39","pubTimestamp":1786876779,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260816:nL4N44D01Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["01548","BK1576","BK1141","HK0000320223.HKD","HK0000320264.USD","BK1583","HK0000306685.HKD","HK0000306701.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152353038","title":"GENSCRIPT BIO Reports Interim Results: Net Loss Narrows 29.25% to $129 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1152353038","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152353038?lang=en_us&edition=fundamental","pubTime":"2026-08-16 18:36","pubTimestamp":1786876574,"startTime":"0","endTime":"0","summary":"GENSCRIPT BIO (01548) has released its interim results for the six months ended June 30, 2026, reporting a 27.35% increase in revenue to $404 million. The company's loss attributable to equity...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1576","HK0000306701.USD","HK0000306685.HKD","BK1583","01548","BK1141","HK0000320264.USD","HK0000320223.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659172894","title":"GenScript FY26 H1 Net Loss Narrows 28.9% to US$ 129.34 Million; Revenue Rises 27.3% to US$ 404.22 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659172894","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659172894?lang=en_us&edition=fundamental","pubTime":"2026-08-16 18:30","pubTimestamp":1786876254,"startTime":"0","endTime":"0","summary":"GenScript FY26 H1 net loss narrows 28.9% to US$ 129.34 million; revenue rises 27.3% to US$ 404.22 millionGenScript Biotech posted a net loss of US$ 129.34 million in the six months ended June 30, 2026","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260816:nNDL63TWN6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01548","HK0000306685.HKD","BK1141","HK0000320223.HKD","BK1576","HK0000306701.USD","BK1583","HK0000320264.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659617141","title":"JD Health International, Inc. (6618) Gets a Buy from CSC Financial","url":"https://stock-news.laohu8.com/highlight/detail?id=2659617141","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659617141?lang=en_us&edition=fundamental","pubTime":"2026-08-16 13:05","pubTimestamp":1786856722,"startTime":"0","endTime":"0","summary":"In a report released yesterday, from CSC Financial maintained a Buy rating on JD Health International, Inc., with a price target of HK$58.27. Curre...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/jd-health-international-inc-6618-gets-a-buy-from-csc-financial-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/jd-health-international-inc-6618-gets-a-buy-from-csc-financial-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK1515","BK1615","BK1571","SGXZ86797644.SGD","86618","SGXZ62798434.SGD","BK1589","LU0051755006.USD","LU0456827905.SGD","BK1583","BK1591","BK1247","06618","BK1142"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659712179","title":"Why Xtep International Holdings (SEHK:1368) Is Back In The Spotlight","url":"https://stock-news.laohu8.com/highlight/detail?id=2659712179","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659712179?lang=en_us&edition=fundamental","pubTime":"2026-08-16 06:28","pubTimestamp":1786832917,"startTime":"0","endTime":"0","summary":"Xtep International Holdings (SEHK:1368) has drawn fresh attention after announcing the global launch of its 160X 8.0 marathon shoe series. The line features GT1200 aerospace-grade carbon plate technology developed with Zhongfu Shenying.\nSee our latest analysis for Xtep International Holdings.\nThe upcoming 160X 8.0 launch has arrived after a tougher period for Xtep International Holdings shareholders, with the share price at HK$3.555 and a year-to-date share price return that has fallen...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/4131000-choice1-main-header/1585186707756","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/4131000-choice1-main-header/1585186707756"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/consumer-durables/hkg-1368/xtep-international-holdings-shares/news/why-xtep-international-holdings-sehk1368-is-back-in-the-spot","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/consumer-durables/hkg-1368/xtep-international-holdings-shares/news/why-xtep-international-holdings-sehk1368-is-back-in-the-spot","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["DECU","BK1502","LU0702159699.USD","LU1166156734.SGD","PMDE","01368","FEBU","BK1583","GXDW","JOYT","RGLO","VGFPF","BK1168","VOTE","LU0702159343.USD","BK1512"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659176018","title":"JD Health (SEHK:6618) Stock Marks Nine Straight Quarters Of Margin Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=2659176018","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659176018?lang=en_us&edition=fundamental","pubTime":"2026-08-16 04:35","pubTimestamp":1786826104,"startTime":"0","endTime":"0","summary":"JD Health International stock has barely moved over the past week, yet the latest half year numbers tell a more energetic story. Revenue reached RMB 40.9b and non IFRS operating income hit RMB 3.5b, which pushed the non IFRS operating margin to 8.5%. That keeps a nine quarter streak of margin gains intact.\nThe market seems to be treating this as just another steady update. The main takeaway is that JD Health International continues to widen its profitability cushion while sitting on RMB 71.5b...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/4422000-choice1-main-header/1585186589176","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/4422000-choice1-main-header/1585186589176"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/consumer-retailing/hkg-6618/jd-health-international-shares/news/jd-health-sehk6618-stock-marks-nine-straight-quarters-of-mar","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/consumer-retailing/hkg-6618/jd-health-international-shares/news/jd-health-sehk6618-stock-marks-nine-straight-quarters-of-mar","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["86618","BK1583","BK1589","06618","BK1591","LU0051755006.USD","BK1247","BK1515","LU0456827905.SGD","SGXZ62798434.SGD","SGXZ86797644.SGD","BK1615","BK1571","BK1142"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659127342","title":"JD Health International, Inc. (6618) Receives a Buy from CLSA","url":"https://stock-news.laohu8.com/highlight/detail?id=2659127342","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659127342?lang=en_us&edition=fundamental","pubTime":"2026-08-15 08:25","pubTimestamp":1786753533,"startTime":"0","endTime":"0","summary":"In a report released yesterday, from CLSA maintained a Buy rating on JD Health International, Inc., with a price target of HK$61.00. The word on Th...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/jd-health-international-inc-6618-receives-a-buy-from-clsa-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/jd-health-international-inc-6618-receives-a-buy-from-clsa-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK1247","BK1583","BK1142","BK1591","SGXZ86797644.SGD","BK1615","LU0456827905.SGD","SGXZ62798434.SGD","LU0051755006.USD","BK1515","06618","BK1589","BK1571","86618"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659147506","title":"Shandong Boan Biotech Completes China Phase Ia Trial of Ba1302 CD228-Targeted ADC","url":"https://stock-news.laohu8.com/highlight/detail?id=2659147506","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659147506?lang=en_us&edition=fundamental","pubTime":"2026-08-14 22:17","pubTimestamp":1786717020,"startTime":"0","endTime":"0","summary":"Shandong Boan Biotech completes China Phase Ia trial of BA1302 CD228-targeted ADCShandong Boan Biotechnology completed China Phase Ia dose-escalation for BA1302, a CD228-targeted antibody-drug conjuga","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nNDLbBDZgq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1606","BK1191","02186","BK1161","06955"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659475541","title":"Shandong Boan Biotech Schedules Board Meeting on Interim Results, Dividend Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2659475541","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659475541?lang=en_us&edition=fundamental","pubTime":"2026-08-14 22:15","pubTimestamp":1786716936,"startTime":"0","endTime":"0","summary":"Shandong Boan Biotech schedules board meeting on interim results, dividend reviewShandong Boan Biotechnology will hold a board meeting on Aug. 27, 2026.Agenda includes reviewing interim results for th","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nNDL3K8zFV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1606","06955","BK1583","02186","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134550271","title":"How CR Mixc Elevates Community Malls: A Deep Dive into Shenzhen Buji Mixc's Premium Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=1134550271","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134550271?lang=en_us&edition=fundamental","pubTime":"2026-08-14 20:10","pubTimestamp":1786709456,"startTime":"0","endTime":"0","summary":"On a slightly humid weekday afternoon, we visited Buji Mixc in Shenzhen. Having previously toured several malls under CHINA RES MIXC, we had a clear expectation of the Mixc positioning and...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["08496","LU0082770016.SGD","BK1583","BK1258","LU0456827905.SGD","BK1132","LU0051755006.USD","LU0164939612.USD","BK1542","LU0620787316.HKD","LU0456846285.SGD","BK1229","01209","LU0082770016.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110314526","title":"JPMorgan Chase & Co. Increases Stake in BEONE MEDICINES by Over 4.1 Million Shares at Approximately HKD 219.79 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=1110314526","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110314526?lang=en_us&edition=fundamental","pubTime":"2026-08-14 19:51","pubTimestamp":1786708275,"startTime":"0","endTime":"0","summary":"Data from the Hong Kong Stock Exchange shows that on August 11, JPMorgan Chase & Co. increased its holdings in BEONE MEDICINES (06160) by 4,119,720 shares.The transaction was executed at an average...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1145028129.USD","SG9999002224.SGD","LU0251132253.USD","LU0310799852.SGD","BK4533","LU1119994496.HKD","LU1244550577.SGD","BK4516","BK4550","LU2552382132.HKD","LU0820561818.USD","LU1974910355.USD","LU0588546209.SGD","LU2505996681.GBP","XLF","IE00B1BXHZ80.USD","LU0238689110.USD","LU1720051108.HKD","LU0345769631.USD","ONC","LU2746668974.SGD","LU1670628061.USD","BK4582","LU0149725797.USD","LU2417539215.USD","LU1988902786.USD","IE00BN8TJ469.HKD","BK1588","LU2106854487.HKD","LU2552382058.USD","BK4566","BK4585","LU1303224171.USD","IE00BFXG1179.USD","LU0265550946.USD","FNCL","BK0239","LU0640476718.USD","IE0034235295.USD","06160","LU1496350171.SGD","LU0828237510.HKD","LU2237443382.USD","LU1917777945.USD","LU0106831901.USD","LU0215105999.USD","LU0048584097.USD","JPMLL","LU1261432733.SGD","JPO","LU1551013342.USD","IE00BZ1G4Q59.USD","IE000M9KFDE8.USD","LU1162221912.USD","LU1267930490.SGD","LU1244550221.USD","LU1548497426.USD","LU2430703095.HKD","VFH","LU2462157665.USD","LU0006306889.USD","LU0882574139.USD","BK4588","IE00BWXC8680.SGD","LU0943347566.SGD","LU0820562030.AUD","IE0034235188.USD","LU2237443978.SGD","LU2244417387.USD","LU1720051017.SGD","LU2237443895.HKD","JPX","LU0234572021.USD","LU0170899867.USD","PGF","LU0868494708.USD","LU0942090050.USD","LU0689472784.USD","TFNS","KURE","LU1914381329.SGD","LU0211331839.USD","LU1244550494.USD","LU2357627491.SGD","LU0211328371.USD","LU0256863811.USD","UYG","IE00BDCRKT87.USD","IE00BDRTCR15.USD","BK4526","LU2237443622.USD","LU0070302665.USD","LU1770034418.SGD","LU0787776722.HKD","IE00BYXW3230.USD","LU1280957306.USD","LU2357305700.SGD","TRUF","LU2236285917.USD","BK4504","LU0976567544.SGD","LU1116320901.HKD","LU1551013425.SGD","LU2237443465.HKD","IE00BJLML261.HKD","IE00B775SV38.USD","LU0345770308.USD","LU0307460666.USD","LU1032466523.USD","BK4207","LU2328871848.SGD","LU2237443549.SGD","BK1500","LU0211326755.USD","LU1894683348.USD","LU2213496289.HKD","LU0859254822.USD","IE00BLSP4239.USD","LU0265550359.USD","IE00BKDWB100.SGD","LU2054465674.USD","JPMO","LU2264538146.SGD","LU2756315664.SGD","LU0820561909.HKD","LU0417517546.SGD","LU1496350502.SGD","LU1366192091.USD","LU0971096721.USD","LU2456880835.USD","IE00BK4W5L77.USD","JPM","LU0228659784.USD","LU0496365809.HKD","LU2430703251.USD","BK1583","LU2211815571.USD","LU1116320737.USD","IE00BK4W5M84.HKD","LU0320765489.SGD","BK4139","688235","FTXO","LU2023250843.SGD","IE00BHPRN162.USD","LU0345769128.USD","LU0267386448.USD","LU0868494617.USD","IXG","LU0234570918.USD","LU0106261372.USD","LU0203347892.USD","LU1670627923.USD","LU1363072403.SGD","LU1894683264.USD","LU1064131342.USD","IYG","LU0256863902.USD","LU2552382215.SGD","LU2505996509.AUD","BK4534","LU1719994722.HKD","LU0211327993.USD","LU0320765646.SGD","IYF","BK4581","IE00BLSP4452.SGD","IE00BBT3K403.USD","LU0211326839.USD","LU0203345920.USD","LU1969619763.USD","LU1251922891.USD","LU2430703178.SGD","LU2023250330.USD","LU1668664300.SGD","SG9999002232.USD","IE00BJTD4V19.USD","EWH","BK1161","IE00B3S45H60.SGD","LU0345770993.USD","IE00B1XK9C88.USD","LU1084165304.USD","LU2756315318.SGD","IE0034235303.USD","LU0323591593.USD","LU1629891620.HKD","LU2746668461.USD","IE00BKVL7J92.USD","LU2023250504.SGD","LU0208291251.USD","LU0187121727.USD","LU0683600562.USD","LU2242649171.HKD","LU2381873111.SGD","KBWB","LU0964807845.USD","IE00BJTD4N35.SGD","LU2592432038.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168518114","title":"Liu Xiaopeng receives approval for vice president role at Cinda Asset","url":"https://stock-news.laohu8.com/highlight/detail?id=1168518114","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168518114?lang=en_us&edition=fundamental","pubTime":"2026-08-14 18:50","pubTimestamp":1786704626,"startTime":"0","endTime":"0","summary":"On August 14, financial frontline sources reported that the National Financial Regulatory Administration issued an approval, ratifying Liu Xiaopeng's qualification to serve as the vice president of China Cinda Asset Management Co., Ltd.","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADVX","BK1583","BK1258","AMGR","PFI","09983","TRUF","GABF","BK1542","BK1229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133459170","title":"Record highs: Beijing-Tianjin-Hebei region sees 15.6% growth in imports and exports for first seven months","url":"https://stock-news.laohu8.com/highlight/detail?id=1133459170","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133459170?lang=en_us&edition=fundamental","pubTime":"2026-08-14 18:49","pubTimestamp":1786704549,"startTime":"0","endTime":"0","summary":"The Beijing-Tianjin-Hebei region has achieved a new milestone, with total imports and exports surging 15.6% year-on-year during the January-July period.This robust growth highlights the region's...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2488822045.USD","BK1233","BK1604","BK1591","BK1589","06862","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659143376","title":"MicroPort CardioFlow Schedules Board Meeting to Review Interim Results, Consider Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2659143376","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659143376?lang=en_us&edition=fundamental","pubTime":"2026-08-14 18:43","pubTimestamp":1786704209,"startTime":"0","endTime":"0","summary":"MicroPort CardioFlow schedules board meeting to review interim results, consider dividendMicroPort CardioFlow Medtech will hold a board meeting on Aug. 26, 2026.Interim results for the six months ende","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nNDL3bT5NX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1585","00853","02160","BK1574","BK1589","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659397143","title":"Xiabuxiabu Schedules Board Meeting to Review Interim Results, Consider Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2659397143","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659397143?lang=en_us&edition=fundamental","pubTime":"2026-08-14 18:40","pubTimestamp":1786704001,"startTime":"0","endTime":"0","summary":"Xiabuxiabu schedules board meeting to review interim results, consider dividendXiabuxiabu scheduled a board meeting for Aug. 27, 2026 to review interim results for the six months ended June 30, 2026.D","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nNDL5pxrqn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1233","BK1604","00520"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659110528","title":"JPMorgan Chase's Short Position in H-Shares of WuXi AppTec Increases to 3.19% on Aug 11 from 2.66% - HKEX","url":"https://stock-news.laohu8.com/highlight/detail?id=2659110528","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659110528?lang=en_us&edition=fundamental","pubTime":"2026-08-14 17:50","pubTimestamp":1786701042,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nFWN44B0SW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["603259","LU2125910500.SGD","LU1934453819.USD","LU0320764599.SGD","LU1979443071.USD","LU0052750758.USD","LU1303224171.USD","LU0327786744.USD","LU0348766576.USD","LU0456842615.SGD","LU2045819591.USD","LU2495084118.USD","LU0708995583.HKD","LU1997244956.HKD","LU1770034418.SGD","LU1808992512.USD","LU1969619763.USD","IE00BPRC5H50.USD","LU1997245177.USD","LU1251922891.USD","LU1997245094.SGD","LU1719994722.HKD","LU0469268626.HKD","IE00B543WZ88.USD","LU0572944931.SGD","LU1046422090.SGD","BK1576","BK1583","LU0700851271.USD","LU2328871848.SGD","LU2488822045.USD","BK1141","IE00B5MMRT66.SGD","LU0348767384.USD","LU0611395673.USD","02359","LU2242644610.SGD","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659111211","title":"Everest Medicines Files Board, Board Committee Member List with Disclosure Responsibilities","url":"https://stock-news.laohu8.com/highlight/detail?id=2659111211","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659111211?lang=en_us&edition=fundamental","pubTime":"2026-08-14 17:06","pubTimestamp":1786698405,"startTime":"0","endTime":"0","summary":"Everest Medicines files board, board committee member list with disclosure responsibilitiesEverest Medicines updated its board and committee roster, naming Wu Yifang as chairman, Luo Yongqing as CEO, ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nNDL5JhNqt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1583","01952","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659162114","title":"Tong Ren Tang Technologies Schedules Board Meeting on Interim Results, Dividend Decision","url":"https://stock-news.laohu8.com/highlight/detail?id=2659162114","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659162114?lang=en_us&edition=fundamental","pubTime":"2026-08-14 16:45","pubTimestamp":1786697127,"startTime":"0","endTime":"0","summary":"Tong Ren Tang Technologies schedules board meeting on interim results, dividend decisionTong Ren Tang Technologies set a board meeting for Aug. 28, 2026 to review interim results for the six months en","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nNDL1KzFsW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0188","BK0012","600085","BK0086","01666","BK0113","BK1515","BK1606","LU1688375341.USD","BK0028","BK0183","BK1191","BK0097","BK0239","BK0196","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659111006","title":"China Resources Mixc Lifestyle Services Schedules Board Meeting to Review Interim Results, Dividend Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2659111006","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659111006?lang=en_us&edition=fundamental","pubTime":"2026-08-14 16:32","pubTimestamp":1786696328,"startTime":"0","endTime":"0","summary":"China Resources Mixc Lifestyle Services schedules board meeting to review interim results, dividend planChina Resources Mixc Lifestyle Services will hold a board meeting on Aug. 28, 2026 to review int","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nNDLblRJJ7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1960683339.HKD","LU0082770016.SGD","BK1542","LU0791591158.USD","LU3063872942.SGD","HK0000306701.USD","LU1366334651.USD","LU1807302812.USD","LU0348825331.USD","LU0414403682.SGD","LU0516422440.USD","LU0456827905.SGD","LU1023057109.AUD","LU0516423091.SGD","BK1229","LU0164939612.USD","IE0008368742.USD","HK0000306685.HKD","01109","LU0048597586.USD","HK0000320223.HKD","LU0359202008.SGD","LU0605514214.HKD","LU0051755006.USD","01209","BK1258","LU0880133367.SGD","LU1993786604.SGD","BK1583","LU2088747998.USD","LU0572940350.SGD","LU0738912210.USD","LU0572939691.SGD","LU0251144936.SGD","LU0173614495.USD","LU0287142896.SGD","LU0456846285.SGD","LU0516423174.USD","BK1521","LU0594300419.USD","LU2088748293.HKD","LU0516422366.SGD","SG9999010078.USD","LU0211977185.USD","LU0516422952.EUR","LU0979878070.USD","LU1880383366.USD","BK1570","LU1152091754.HKD","LU2088748020.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659114810","title":"Haidilao International Holding Stock Falls 1.5% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2659114810","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659114810?lang=en_us&edition=fundamental","pubTime":"2026-08-14 16:32","pubTimestamp":1786696320,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Haidilao International Holding Ltd. slipped 1.5% to 11.42 Hong Kong dollars on what proved to be an all-around dismal trading session for the Hong Kong stock market, with the Hang Seng Index falling 1.1% to 25116.85.This was the stock's third consecutive day of losses.Haidilao International Holding Ltd. closed 36% below its 52-week high of HK$17.86, which the company reached Feb. 26.Trading volume totaled 11.8 million shares, compared to the 50-day average of 12.8 million shares.Data source: Dow Jones Market Data, FactSet","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","06862","LU2488822045.USD","BK1604","BK1591","BK1589","BK1233"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":17,"pageCount":12,"totalSize":337,"code":"91000000","status":"200"}]}}